The President of the European Council, Charles Michel, ensures that the laboratories maintain the initial calendar of vacancies in the European Union from 25 January, after which Brussels intervenes to comply with the contracts.
“We want to ensure that the contracts that are validated by the pharmaceuticals and our compromises are respected and that there is transparency using all the legal media of those that are available”, said Michel in the French emissary Europe 1.
The President of the European Council insists that Brussels has stated that “there will be a wave over the moon”, in order to clarify the reasons for its withdrawal.
And he also paid for the companies that he had with the transparency of the reasons for the debts he had paid had difficulties in the production chain.
“When he announced returns, for example in the Pfizer case, we acted with the company, we made a mistake about the month and finally the returns of various weeks were reduced to delays in the delivery”, added.
MICHEL PIDIÓ CLARIDAD ABOUT CINCO O SEIS DOSIS POR FRASCO
Michel indicates that he has applied to the European Medicines Agency for clarification and scientific arguments regarding the dose number available for use, which according to the Pfizer laboratory is limited to the sanitary authorities considered to have six allowed to balance the back.
“It is necessary that in all of Europe we have the same interpretation,” said Michel.